The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Open accessAbstract
Peptide therapeutics have played a notable role in medical practice since the advent of insulin therapy in the 1920s. Over 60 peptide drugs are approved in the United States and other major markets, and peptides continue to enter clinical development at a steady pace. Peptide drug discovery has diversified beyond its traditional focus on endogenous human peptides to include a broader range of structures identified from other natural sources or through medicinal chemistry efforts. We maintain a comprehensive dataset on peptides that have entered human clinical studies that includes over 150 peptides in active development today. Here we provide an overview of the peptide therapeutic landscape, including historical perspectives, molecular characteristics, regulatory benchmarks, and a therapeutic area breakdown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Peptides (2–50 amino acids) and proteins (more than 50 amino acids) have better selectivity for human specific targets. The larger molecular size and diverse quaternary structure enhance their interaction with specific protein pockets, making peptides and protein drugs have better biological activity and lower toxicity than small molecules.294,295”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [294]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Müller, A., Schäberle, T. F., Hughes, D. E., Epstein, S. S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052
Advances in Fmoc solid‐phase peptide synthesis
Behrendt, R., White, P., & Offer, J. (2016) · Journal of Peptide Science · doi:10.1002/psc.2836 · Cited by 767
(1922) · PubMed · Cited by 753
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007218 · Cited by 696
Chang, Y. S., Graves, B. J., Guerlavais, V., Tovar, C., Packman, K. E., To, K.-H., Olson, K. A., Kesavan, K. P., Gangurde, P., Mukherjee, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303002110 · Cited by 681
Strategic Approaches to Optimizing Peptide ADME Properties
Di, L. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9687-3 · Cited by 669
Large-scale manufacture of peptide therapeutics by chemical synthesis
Bray, B. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1133 · Cited by 601
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., Saha, P. K., Del Solar, M., Zhu, B., York, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.063 · Cited by 591
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 1,001
The emerging landscape of peptide-based inhibitors of PCSK9
Tombling, B. J., Zhang, Y., Huang, Y., Craik, D. J., & Wang, C. K. L. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.06.903 · Cited by 34
Hjalte, J., Hossain, S., Hugerth, A., Sjögren, H., Wahlgren, M., Larsson, P., & Lundberg, D. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00883 · Cited by 35
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Liu, J., Ting, J. P., Al-Azzam, S., Ding, Y., & Afshar, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062805 · Cited by 37
Studying Peptide-Metal Ion Complex Structures by Solution-State NMR
Shalev, D. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415957 · Cited by 33
Tripathi, A. K., Singh, J., Trivedi, R., & Ranade, P. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14110539 · Cited by 34
Peptide Therapeutics: Unveiling the Potential against Cancer—A Journey through 1989
Musaimi, O. A. (2024) · Cancers · doi:10.3390/cancers16051032 · Cited by 37
Focus on therapeutic peptides and their delivery
Rosson, E., Lux, F., David, L., Godfrin, Y., Tillement, O., & Thomas, E. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125555 · Cited by 36
Overview of intranasally delivered peptides: key considerations for pharmaceutical development
Bakri, W. A., Donovan, M. D., Cueto, M. A., Wu, Y., Orekie, C., & Yang, Z. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1517742 · Cited by 34
Receptor selectivity from minimal backbone modification of a polypeptide agonist
Liu, S., Cheloha, R. W., Watanabe, T., Gardella, T. J., & Gellman, S. H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815294115 · Cited by 34
Okada, C. Y., dos Santos, C. Y., & Jurberg, I. D. (2020) · Tetrahedron · doi:10.1016/j.tet.2020.131316 · Cited by 34
Subramanian, K., Iovino, F., Tsikourkitoudi, V. P., Merkl, P., Ahmed, S., Berry, S. B., Aschtgen, M., Svensson, M., Bergman, P., Sotiriou, G. A., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012695 · Cited by 33
Sindhikara, D., Wagner, M., Gkeka, P., Güssregen, S., Tiwari, G., Heßler, G., Yapici, E., Li, Z., & Evers, A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01500 · Cited by 35
Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19
Shah, J. N., Guo, G., Krishnan, A., Ramesh, M., Katari, N. K., Shahbaaz, M., Abdellattif, M. H., Singh, S. K., & Dua, K. (2021) · Therapies · doi:10.1016/j.therap.2021.09.007 · Cited by 38
Discovery of a New Analgesic Peptide, Leptucin, from the Iranian Scorpion, Hemiscorpius lepturus
Bagheri-Ziari, S., Shahbazzadeh, D., Sardari, S., Sabatier, J., & Bagheri, K. P. (2021) · Molecules · doi:10.3390/molecules26092580 · Cited by 33
Clickable tryptophan modification for late-stage diversification of native peptides
Xiao, Y., Zhou, H., Shi, P., Zhao, X., Liu, H., & Li, X. (2024) · Science Advances · doi:10.1126/sciadv.adp9958 · Cited by 33
Verma, P., Bannon, M. S., Kuenen, M. K., Raj, S. S. S., Dhakal, A., Stone, K. H., Nichols, A. W., Machan, C. W., Colón, Y. J., Letteri, R. A., et al. (2024) · Chemistry of Materials · doi:10.1021/acs.chemmater.4c00112 · Cited by 33
Methods for engineering therapeutic peptides
Li, Y., Clark, K. A., & Tan, Z. (2018) · Chinese Chemical Letters · doi:10.1016/j.cclet.2018.05.027 · Cited by 33
Luca, C. D., Felletti, S., Macis, M., Cabri, W., Lievore, G., Chenet, T., Pasti, L., Morbidelli, M., Cavazzini, A., Catani, M., et al. (2019) · Journal of Chromatography A · doi:10.1016/j.chroma.2019.460789 · Cited by 33
Smith, S. J., Li, C. M., Lingeman, R. G., Hickey, R. J., Liu, Y., Malkas, L. H., & Raoof, M. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.025 · Cited by 33
Therapeutic peptides for chemotherapy: Trends and challenges for advanced delivery systems
Ilangala, A. B., Lechanteur, A., Fillet, M., & Piel, G. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.07.010 · Cited by 35
Přibylka, A., Pastorek, M., Grepl, M., & Schütznerová, E. (2021) · Tetrahedron · doi:10.1016/j.tet.2021.132452 · Cited by 33
S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases
Kurpet, K., & Chwatko, G. (2022) · Molecules · doi:10.3390/molecules27196640 · Cited by 33
Editorial: Antimicrobial peptides and their druggability, bio-safety, stability, and resistance
Ma, X., Aminov, R. I., Franco, O. L., de la Fuente‐Núñez, C., Wang, G., & Wang, J. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1425952 · Cited by 33
Patel, S., Vyas, V. K., & Mehta, P. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10492-8 · Cited by 35
Martins, P., Mariano, D., Carvalho, F. C., Bastos, L. L., Moraes, L., Paixão, V. M., & de Melo-Minardi, R. C. (2023) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2023.1103103 · Cited by 35
Selvarajan, V., Tram, N. D. T., Xu, J. X., Ngen, S. T. Y., Koh, J.-J., Teo, J. W. P., Yuen, T., & Ee, P. L. R. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00140 · Cited by 33
Regenerative therapies as a potential treatment of erectile dysfunction
Chung, D. Y., Ryu, J., & Yin, G. N. (2023) · Korean journal of urology · doi:10.4111/icu.20230104 · Cited by 32
Design of an Anti-HMGB1 Synthetic Antibody for In Vivo Ischemic/Reperfusion Injury Therapy
Koide, H., Kiyokawa, C., Okishima, A., Saito, K., Yoshimatsu, K., Fukuta, T., Hoshino, Y., Asai, T., Nishimura, Y., Miura, Y., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c06799 · Cited by 33
Wu, W., Li, G., Dong, S., Chu, C. H., Ma, S., Zhang, Z.-W., Yuan, S., Jin, W., Guo, Z., Shen, Y., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111423 · Cited by 33
Bridging machine learning and peptide design for cancer treatment: a comprehensive review
Rezaee, K., & Eslami, H. (2025) · Artificial Intelligence Review · doi:10.1007/s10462-025-11148-3 · Cited by 34
Bertrand, B., & Muñóz-Garay, C. (2018) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-018-9789-3 · Cited by 33
Nadal‐Bufí, F., & Henriques, S. T. (2020) · Peptide Science · doi:10.1002/pep2.24168 · Cited by 33
Monty, O. B. C., Simmons, N., Chamakuri, S., Matzuk, M. M., & Young, D. W. (2020) · ACS Combinatorial Science · doi:10.1021/acscombsci.0c00144 · Cited by 32
Liu, S., Brul, S., & Zaat, S. A. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238967 · Cited by 34
Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids
Spitalieri, P., Centofanti, F., Murdocca, M., Scioli, M. G., Latini, A., Cesare, S. D., Citro, G., Rossi, A., Orlandi, A., Miersch, S., et al. (2022) · Cells · doi:10.3390/cells11071235 · Cited by 31
Late‐Stage Functionalization of Histidine in Unprotected Peptides
Noisier, A. F. M., Johansson, M. J., Knerr, L., Hayes, M. A., Drury, W. J., Valeur, E., Malins, L. R., & Gopalakrishnan, R. (2019) · Angewandte Chemie · doi:10.1002/ange.201910888 · Cited by 32
Neuroprotective Peptides and New Strategies for Ischemic Stroke Drug Discoveries
Dergunova, L. V., Filippenkov, I. B., Limborska, S. A., & Myasoedov, N. F. (2023) · Genes · doi:10.3390/genes14050953 · Cited by 34
Biomaterials for Protein Delivery: Opportunities and Challenges to Clinical Translation
Gorantla, A., Hall, J., Troidle, A., & Janjic, J. M. (2024) · Micromachines · doi:10.3390/mi15040533 · Cited by 31
Atangcho, L., Navaratna, T. A., & Thurber, G. M. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.11.008 · Cited by 33
Quality Control of Therapeutic Peptides by 1H NMR HiFSA Sequencing
Choules, M. P., Bisson, J. I., Gao, W., Lankin, D. C., McAlpine, J. B., Niemitz, M., Jaki, B. U., Franzblau, S. G., & Pauli, G. F. (2019) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b02704 · Cited by 31
Strategies to Enhance Metabolic Stabilities
Khatri, B., Nuthakki, V. R., & Chatterjee, J. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9504-2_2 · Cited by 32
Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
Javaid, N., Yasmeen, F., & Choi, S. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090441 · Cited by 31
Csire, G., Canabady‐Rochelle, L., Averlant‐Petit, M., Selmeczi, K., & Stefan, L. (2020) · Metallomics · doi:10.1039/d0mt00103a · Cited by 38
Silanol: a bifunctional group for peptide synthesis and late-stage functionalization
Hu, Q.-L., Hou, K., Li, J., Yang, G., Song, Z., Chan, A. S. C., & Xiong, X. (2020) · Chemical Science · doi:10.1039/d0sc02439b · Cited by 31
Computational structure modeling for diverse categories of macromolecular interactions
Aderinwale, T. W., Christoffer, C. W., Sarkar, D., Alnabati, E., & Kihara, D. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.05.017 · Cited by 31
Targeting epigenetic reader domains by chemical biology
Cipriano, A., Sbardella, G., & Ciulli, A. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.05.006 · Cited by 30
Sekar, J., Teng, W., Dahms, H.-U., Liu, W., Ponnusamy, V. K., Chiu, C. C.-C., Kumar, B. S., & Sivakumar, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-70516-x · Cited by 31
Wu, M., Su, A., Chen, Q., Chen, X.-Y., Li, H., Li, Y., & Zhao, X. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00355 · Cited by 32
Kuerban, A., Al‐Malki, A. L., Kumosani, T. A., Sheikh, R. A., Al-Abbasi, F. A., Alshubaily, F. A., Abulnaja, K. O., & Moselhy, S. S. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13494 · Cited by 31
Wang, P., Cheng, Y., Wu, C., Zhou, Y., Cheng, Z., Li, H., Wang, R., Su, W., & Fang, L. (2021) · Organic Letters · doi:10.1021/acs.orglett.1c01013 · Cited by 31
Anticancer activity of protein fractions from chia ( Salvia hispanica L .)
Bojórquez, N. D. C. Q., Carrillo‐Cocom, L. M., Hernández‐Álvarez, A. J., & Campos, M. R. S. (2021) · Journal of Food Science · doi:10.1111/1750-3841.15780 · Cited by 31
Monroe, M. K., Wang, H., Anderson, C. F., Jia, H., Flexner, C. W., & Cui, H. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.037 · Cited by 31
Stefanov, B., & Fussenegger, M. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.986210 · Cited by 31
Hansen, S., Zhang, Y., Hwang, S., Nabhan, A. N., Li, W., Fuhrmann, J., Kschonsak, Y. T., Zhou, L., Nile, A. H., Gao, X., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2207327119 · Cited by 30
Liu, X., Ji, X., Heinis, C., & Waser, J. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202306036 · Cited by 31
Lian, Z., Wang, N., Tian, Y., & Huang, L. (2021) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.0c00479 · Cited by 30
Synthesis of Fluorescent Cyclic Peptides via Gold(I)-Catalyzed Macrocyclization
Liu, X., Cai, W., Ronceray, N., Rađenović, A., Fierz, B., & Waser, J. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c09261 · Cited by 30
Enantioselective organocatalytic strategies to access noncanonical α-amino acids
Pecchini, P., Fochi, M., Bartoccini, F., Piersanti, G., & Bernardi, L. (2024) · Chemical Science · doi:10.1039/d4sc01081g · Cited by 30
Continuous-Flow Solid-Phase Peptide Synthesis to Enable Rapid, Multigram Deliveries of Peptides
Ruhl, K. E., Maso, M. J. D., Rose, H. B., Schultz, D. M., Lévesque, F., Grosser, S. T., Silverman, S. M., Li, S., Sciammetta, N., & Mansoor, U. F. (2024) · Organic Process Research & Development · doi:10.1021/acs.oprd.4c00165 · Cited by 33
Synthesis of Constrained Tetracyclic Peptides by Consecutive CEPS, CLIPS, and Oxime Ligation
Streefkerk, D. E., Schmidt, M., Ippel, H., Hackeng, T. M., Nuijens, T., Timmerman, P., & van Maarseveen, J. H. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b00378 · Cited by 30
Cameron, A. J., Harris, P. W. R., & Brimble, M. A. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004656 · Cited by 30
Automated affinity selection for rapid discovery of peptide binders
Zhang, G., Li, C., Quartararo, A. J., Loas, A., & Pentelute, B. L. (2021) · Chemical Science · doi:10.1039/d1sc02587b · Cited by 30
Origin of Proteolytic Stability of Peptide-Brush Polymers as Globular Proteomimetics
Sun, H. R., Qiao, B., Choi, W., Hampu, N., McCallum, N. C., Thompson, M. P., Oktawiec, J., Weigand, S. L., Ebrahim, O. M., de la Cruz, M. O., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c01149 · Cited by 31
Non-Covalent Albumin Ligands in FDA-Approved Therapeutic Peptides and Proteins
Zaragoza, F. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01021 · Cited by 30
Koran, K., Çalışkan, E., Öztürk, D. A., Çapan, İ., Tekin, S., Sandal, S., & Görgülü, A. O. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106338 · Cited by 30
Diabetic Neuropathy of the Retina and Inflammation: Perspectives
Мухаррамовна, Б. Г., Oshitari, T., & Bikbov, M. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119166 · Cited by 32
Gregorc, J., Lensen, N., Chaume, G., Iskra, J., & Brigaud, T. (2023) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.3c01373 · Cited by 30
Bai, Q., Bai, Z., & Wang, H. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b02945 · Cited by 29
Li, Y., Cao, X., Tian, C., & Zheng, J. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.04.015 · Cited by 29
Solid-phase fluorescent BODIPY–peptide synthesis via in situ dipyrrin construction
Wu, Y., Tam, W., Chau, H.-F., Kaur, S., Thor, W., Aik, W. S., Chan, W., Zweckstetter, M., & Wong, K. (2020) · Chemical Science · doi:10.1039/d0sc04849f · Cited by 29
Dahlgren, D., Olander, T., Sjöblom, M., Hedeland, M., & Lennernäs, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.019 · Cited by 29
Dauer, K., Pfeiffer‐Marek, S., Kamm, W., & Wagner, K. G. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020172 · Cited by 29
Doyen, C., Larquet, É., Coureux, P., Frances, O., Herman, F., Sablé, S., Burnouf, J.-P., Sizun, C., & Lescop, E. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00037 · Cited by 29
Hydrophobic-hydrophilic Alternation: An effective Pattern to de novo Designed Antimicrobial Peptides
Zeng, P., & Cheng, Q. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220902124856 · Cited by 31
Afonin, S., Babii, O., Reuter, A., Middel, V., Takamiya, M., Strähle, U., Komarov, I. V., & Ulrich, A. S. (2020) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.16.6 · Cited by 29
Mutexa: A Computational Ecosystem for Intelligent Protein Engineering
Yang, Z. J., Shao, Q., Jiang, Y., Jurich, C., Ran, X., Juarez, R. J., Yan, B., Stull, S. L., Gollu, A., & Ding, N. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.3c00602 · Cited by 28
Construction of Targeting-Peptide-Based Imaging Reagents and Their Application in Bioimaging
Zhang, L., Wang, X., Zhao, J., Sun, B., & Wang, W. (2023) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.3c00104 · Cited by 28
Sepúlveda-Rivas, S., Fritz, H. F., Valenzuela, C., Santiviago, C. A., & Morales, J. O. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030103 · Cited by 28
Karongo, R., Ikegami, T., Stoll, D. R., & Lämmerhofer, M. (2020) · Journal of Chromatography A · doi:10.1016/j.chroma.2020.461430 · Cited by 28
Santalices, I., Vázquez‐Vázquez, C., Santander-Ortega, M. J., Lozano, M. V., Araújo, F., Sarmento, B. F. C. C., Shrestha, N., Véronique Préat, A., Chenlo, M., Álvarez, C. V., et al. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00920-x · Cited by 28
Liu, S., Cai, C., Bai, Z., Sheng, W., Tan, J., & Wang, H. (2021) · Organic Letters · doi:10.1021/acs.orglett.1c00580 · Cited by 28
Cell-penetrating peptides as part of therapeutics used in cancer research
Matijass, M., & Neundorf, I. (2021) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2021.100092 · Cited by 28
Solid-Phase Photochemical Decarboxylative Hydroalkylation of Peptides
Elkhalifa, M. A., Elbaum, M. B., Chenoweth, D. M., & Molander, G. A. (2021) · Organic Letters · doi:10.1021/acs.orglett.1c02928 · Cited by 28
Brittain, W. D. G., & Coxon, C. R. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202103305 · Cited by 28
Molla, M. H. R., & Aljahdali, M. O. (2022) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2022.102346 · Cited by 28
Recent Progress in Electrochemical Modification of Amino Acids and Peptides
Fang, X., Huang, Y., Hu, X., & Ruan, Z. (2024) · Chinese Journal of Organic Chemistry · doi:10.6023/cjoc202310024 · Cited by 28
Peptipedia v2.0: a peptide sequence database and user-friendly web platform. A major update
Cabas-Mora, G., Daza, A., Soto-García, N., Garrido, V., Alvarez, D., Navarrete, M., Sarmiento-Varón, L., Sepúlveda Yañez, J. H., Davari, M. D., Cadet, F., et al. (2024) · Database · doi:10.1093/database/baae113 · Cited by 35
ANNprob-ACPs: A novel anticancer peptide identifier based on probabilistic feature fusion approach
Karim, T., Shaon, M. S. H., Sultan, M. F., Hasan, M. Z., & Kafy, A. ‐. A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107915 · Cited by 27
Targeted Radionuclide Therapy in Glioblastoma
Zhao, X., Jakobsson, V., Tao, Y., Zhao, T., Wang, J., Khong, P., Chen, X. S., & Zhang, J. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c07850 · Cited by 27
Mazzoccanti, G., Manetto, S., Ricci, A., Cabri, W., Orlandin, A., Catani, M., Felletti, S., Cavazzini, A., Ye, M., Ritchie, H. J., et al. (2020) · Journal of Chromatography A · doi:10.1016/j.chroma.2020.461235 · Cited by 27
Doping control analysis of small peptides: A decade of progress
Judák, P., Esposito, S., Coppieters, G., Eenoo, P. V., & Deventer, K. (2021) · Journal of Chromatography B · doi:10.1016/j.jchromb.2021.122551 · Cited by 27
Library and post-translational modifications of peptide-based display systems
Dotter, H., Boll, M., Eder, M., & Eder, A.-C. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107699 · Cited by 27
HemoNet: Predicting hemolytic activity of peptides with integrated feature learning
Yaseen, A., Gull, S., Akhtar, N., Amin, I. U., & Minhas, F. (2021) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720021500219 · Cited by 27
Molineau, J., Hideux, M., Hennig, P., Bertin, S., Mauge, F., Lesellier, É., & West, C. (2021) · Journal of Chromatography A · doi:10.1016/j.chroma.2021.462771 · Cited by 27
Bioactive peptides from nuts: A review
Acevedo‐Juárez, S., Guajardo‐Flores, D., Heredia‐Olea, E., & Antunes‐Ricardo, M. (2022) · International Journal of Food Science & Technology · doi:10.1111/ijfs.15543 · Cited by 27
Therapeutic potential of ApoE-mimetic peptides in CNS disorders: Current perspective
Ahmed, S., Pande, A. H., & Sharma, S. S. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114051 · Cited by 29
Conjugates for use in peptide therapeutics: A systematic review and meta-analysis
Wijesinghe, A., Kumari, S., & Booth, V. K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0255753 · Cited by 28
From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs
L’Hôte, V., Mann, C., & Thuret, J. (2022) · Open Biology · doi:10.1098/rsob.220171 · Cited by 27
Glucagon-like peptide 1 aggregates into low-molecular-weight oligomers off-pathway to fibrillation
Brichtová, E., Krupová, M., Bouř, P., Lindo, V., dos Santos, A. G., & Jackson, S. (2023) · Biophysical Journal · doi:10.1016/j.bpj.2023.04.027 · Cited by 26
Molecular basis of the therapeutic properties of hemorphins
Ali, A., Alzeyoudi, S. A. R., Almutawa, S. A., Alnajjar, A. N., & Vijayan, R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104855 · Cited by 28
Metadata
- Authors
- Lau, J. L., & Dunn, M. K.
- Affiliations
- Ferring Research Institute (United States) (US)
- Corresponding author
- Dunn, Michael K.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 26
- Issue
- 10
- Pages
- 2700-2707
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2724823461
- Cited by
- 1,879
- References
- 44
- Citations by year
- 2026: 146 · 2025: 179 · 2024: 205 · 2023: 236 · 2022: 299 · 2021: 275 · 2020: 278 · 2019: 194 · 2018: 59
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Bioorganic & Medicinal Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- peptide therapeutics, peptide drug discovery, clinical development, insulin, therapeutic areas
- MeSH terms
- Animals, Drug Evaluation, Humans, Peptides, Drug Approval, Drug Discovery, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review